Akari Therapeutics Plc Adr (AKTX)

Jun 18, 2025

Akari Therapeutics secures Indian patent for cancer drug payload - Investing.com India

Jun 18, 2025

May 17, 2025

Akari Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 17, 2025

May 01, 2025

Akari Therapeutics appoints new head of oncology business By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Akari Therapeutics appoints new head of oncology business - Investing.com

May 01, 2025

Apr 17, 2025

Akari Therapeutics Advances ADC Development Amid Financial Challenges - TipRanks

Apr 17, 2025

Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation - Investing.com India

Mar 20, 2025

Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Ibotta Inc (IBTA) Shares Soar Above 1-Year High - The News Heater

Mar 20, 2025

Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down - Investing.com

Mar 20, 2025

Mar 03, 2025

Akari Therapeutics secures $7.6 million in private placement - Investing.com India

Mar 03, 2025

Feb 03, 2025

Major ADC Developer Akari Opens Direct Channel to Investors Through Webull Platform - StockTitan

Feb 03, 2025

Dec 28, 2024

Akari Therapeutics, Plc (NASDAQ:AKTX) Sees Significant Growth in Short Interest - Defense World

Dec 28, 2024

Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024

Dec 16, 2024

AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan

Dec 16, 2024

Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024

Nov 19, 2024

Akari Therapeutics Regains Nasdaq Compliance, Secures Market Listing Status - StockTitan

Nov 19, 2024

Nov 14, 2024

Akari Therapeutics Completes Peak Bio Merger, Secures $53.2M in Financing Commitments - StockTitan

Nov 14, 2024

Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger - Investing.com

Nov 08, 2024

Oct 05, 2024

Akari Therapeutics Plc faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 05, 2024

Jun 05, 2024

Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders - StockTitan

Jun 05, 2024

Sep 29, 2023

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights - StockTitan

Sep 29, 2023

Apr 11, 2023

Akari Therapeutics to Attend ARVO 2023, the Annual Meeting of The Association for Research in Vision and Ophthalmology - StockTitan

Apr 11, 2023

Mar 30, 2023

Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering - StockTitan

Mar 30, 2023

Nov 04, 2022

Peak Bio (PKBO) Stock Price, News & Analysis - MarketBeat

Nov 04, 2022

Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021

Jan 02, 2017

Akari Therapeutics PLC Stock Price Today | NASDAQ: AKTX Live - Investing.com

Jan 02, 2017

Aug 18, 2016

Angion Biomedica (ANGN) Stock Price, News & Analysis - MarketBeat

Aug 18, 2016

Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011